A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB)

A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB)

Introduction Neisseria meningitidis causes invasive meningococcal disease and, globally, significant morbidity, with serogroup B (MenB) being the most common cause of endemic disease and outbreaks in several regions. Extensive use of the four-component serogroup B meningococcal vaccine (4CMenB; Bexs...

Cijeli opis

Bibliografski detalji
Glavni autori: Gary S. Marshall, Victoria Abbing-Karahagopian, Helen S. Marshall, Silvia Cenci, James H. Conway, Emilia Occhipinti, Rafik Bekkat-Berkani, Angelika Banzhoff, Woo-Yun Sohn
Format: Članak
Jezik:English
Izdano: Taylor & Francis Group 2023-12-01
Serija:Expert Review of Vaccines
Teme:
4cmenb
clinical trials
meningococcal serogroup b vaccine
safety
surveillance
Online pristup:http://dx.doi.org/10.1080/14760584.2023.2222015

Internet

http://dx.doi.org/10.1080/14760584.2023.2222015

Slični predmeti